Condition: Endometrial Cancer · Atypical Endometrial Hyperplasia · Sponsor: West China Second University Hospital
Primary end points: This clinical trial is aimed to analyze the effectiveness of Levonorgestrel-Releasing Intrauterine System (LNG-IUS, Mirena®) in the fertility-sparing treatment of atypical endometrial hyperplasia and early endometrial carcinoma, including pathology response and pregnancy outcome. Second end points: To analyze the appearances of side-effects.
This description comes directly from the study's public registry record.
ZHENG Ying, Professor · +8613018256012 · 935398163@qq.com
CHEN Si Jing, postgraduate · +86218380361314 · Zhy_chd@126.com
Always discuss trial participation with your own doctor first.
| West China Second University Hospital | Chengdu, Sichuan, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03463252